en   |   it


Alto Partners has acquired a 100% stake of Mipharm, one of the Italian leader in the pharmaceutical CDMO market

Established in 1998, Mipharm, is active in the development and manufacturing for third parties of a broad spectrum of products, both branded and white label. Mipharm operates through an integrated and state-of-the-art manufacturing site and offers its clients R&D services through a dedicated business unit DVRCAPITAL co-invested with Alto Partners | March 2022

DVR Capital is a portrait site only, turn you device!